Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Horowitz, MJ |
Flashbacks: Recurrent Intrusive Images After the Use of LSD |
Am J Psychiatry |
1969 |
Thurlow HJ, Girvin JP |
Use of anti-epileptic medication in treating 'flashbacks' from halluci... |
Can Med Assoc J |
1971 |
Moskowitz D |
Use of haloperidol to reduce LSD flashbacks |
Mil Med |
1971 |
Stanton MD, Bardoni A |
Drug Flashbacks: Reported Frequency in a Mililtary Population |
Am J Psychiatry |
1972 |
Juve JL |
Bad drug trips and flashbacks |
Child Welfare |
1972 |
Heaton RK |
Subject expectancy and environmental factors as determinants of psyche... |
J Nerv Ment Dis |
1975 |
Holsten F |
Flashbacks: a personal follow-up |
Arch Psychiatr Nerve... |
1976 |
Wesson DR, Smith DE |
An analysis of psychedelic drug flashbacks |
Am J Drug Alcohol Ab... |
1976 |
Matefy RE, Hayes C, Hirsc... |
Psychedelic drug flashbacks: subjective reports and biographical data |
Addict Behav |
1978 |
Abraham HD |
A chronic impairment of colour vision in users of LSD |
Br J Psychiatry |
1982 |
Abraham HD |
Visual phenomenology of the LSD flashback |
Arch Gen Psychiatry |
1983 |
Hoffman JA |
LSD flashbacks |
Arch Gen Psychiatry |
1984 |
Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
Alper RH |
Hemodynamic and renin responses to (+-)-DOI, a selective 5-HT2 recepto... |
Eur J Pharmacol |
1990 |
Creighton FJ, Black DL, H... |
'Ecstasy' psychosis and flashbacks |
Br J Psychiatry |
1991 |
Preston A |
Pointing out the Risk |
Nursing Times |
1992 |
McGuire P, Fahy T |
Flashbacks following MDMA |
Br J Psychiatry |
1992 |
Wodarz N |
'Ecstasy'-induced psychotic depersonalization syndrome |
Nervenarzt |
1993 |
Abraham HD |
Adverse consequences of lysergic acid diethylamide |
Addiction |
1993 |
McGuire PK, Cope H, Fahy ... |
Diversity of psychopathology associated with use of 3,4-methylenedioxy... |
Br J Psychiatry |
1994 |
Abraham HD, Duffy FH |
Stable quantitative EEG difference in post-LSD visual disorder by spli... |
Psychiatry Res |
1996 |
Abraham HD, Mamen A |
LSD-like panic from risperidone in post-LSD visual disorder |
J Clin Psychopharmac... |
1996 |
Kawasaki A, Purvin V |
Persistent palinopsia following ingestion of lysergic acid diethylamid... |
Arch Ophthalmol |
1996 |
Van Toi V, Abraham H, Bu... |
Post-LSD Hallucinosis Is Associated With Decrease In Flicker-Fusion Se... |
Investigative Ophtha... |
1996 |
Tsatsakis AM, Michalodimi... |
MDEA related death in Crete: a case report and literature review |
Vet Hum Toxicol |
1997 |
Morehead DB |
Exacerbation of hallucinogen-persisting perception disorder with rispe... |
J Clin Psychopharmac... |
1997 |
Lerner AG |
Naltrexone treatment of hallucinogen persisting perception disorder |
Am J Psychiatry |
1997 |
Young CR |
Sertaline treatment of hallucinogen persisting perception disorder |
J Clin Psychiatry |
1997 |
Alcantara AG |
Is there a role for the alpha2 antagonism in the exacerbation of hallu... |
J Clin Psychopharmac... |
1998 |
Lerner AG |
Clonidine treatment for hallucinogen persisting perception disorder |
Am J Psychiatry |
1998 |
Myers LS, Watkins SS, Car... |
Flashbacks in Theory and Practice |
The Heffter Review o... |
1998 |
Bailly D |
Neuropsychiatric disorders induced by MDMA ('Ecstasy') |
Encephale |
1999 |
Batzer W, Ditzler T, Brow... |
LSD use and flashbacks in alcoholic patients |
J Addict Dis |
1999 |
Lauterbach EC, Abdelhamid... |
Posthallucinogen-like visual illusions (palinopsia) with risperidone i... |
Pharmacopsychiatry |
2000 |
Lerner AG, Gelkopf M, Oyf... |
LSD-induced hallucinogen persisting perception disorder treatment with... |
Int Clin Psychopharm... |
2000 |
Pomeranz HD, Lessell S |
Palinopsia and polyopia in the absence of drugs or cerebral disease |
Neurology |
2000 |
Genova P |
The Permanent Trip: A case of 'post-hallucinogen perception disorder' |
The Thaw: 24 Essays ... |
2000 |
Abraham HD, Hopkins Duffy... |
EEG coherence in post-LSD visual hallucinations |
Psychiatry Res |
2001 |
Aldurra G, Crayton JW |
Improvement of hallucinogen persisting perception disorder by treatmen... |
J Clin Psychopharmac... |
2001 |
Lerner AG, Skladman I, Ko... |
LSD-induced Hallucinogen Persisting Perception Disorder treated with c... |
Isr J Psychiatry Rel... |
2001 |
Every-Palmer S |
Synthetic cannabinoid JWH-018 and psychosis: An explorative study |
Drug Alcohol Depend |
2011 |
Fröhlich S, Lambe E, O'De... |
Acute liver failure following recreational use of psychotropic 'head s... |
Ir J Med Sci |
2011 |
Sumnall HR, Evans-Brown M... |
Social, policy, and public health perspectives on new psychoactive sub... |
Drug Test Anal |
2011 |
Carroll FI, Lewin AH, Mas... |
Designer drugs: a medicinal chemistry perspective |
Ann N Y Acad Sci |
2011 |
Carroll FI, Lewin AH, Mas... |
Designer drugs: a medicinal chemistry perspective |
Ann N Y Acad Sci |
2011 |
Prosser JM, Nelson LS |
The Toxicology of Bath Salts: A Review of Synthetic Cathinones |
J Med Toxicol |
2012 |
Viscomi CM, Covington M, ... |
Pill Counts and Pill Rental: Unintended Entrepreneurial Opportunities |
Clin J Pain |
2013 |
Johnson LA, Johnson RL, P... |
Current 'Legal Highs' |
J Emerg Med |
2013 |
Barnett RY, Baker DD, Kel... |
A fatal intoxication of 2,5-dimethoxy-4-chloroamphetamine: a case repo... |
J Anal Toxicol |
2014 |
Wallach J, Kang H, Colest... |
Pharmacological Investigations of the Dissociative 'Legal Highs' Diphe... |
PLoS One |
2016 |
Moosmann B, Auwärter V |
Designer Benzodiazepines: Another Class of New Psychoactive Substances |
Handb Exp Pharmacol |
2018 |
Vandeputte MM, Krotulski ... |
Phenethyl-4-ANPP: a Marginally Active Byproduct Suggesting a Switch in... |
J Anal Toxicol |
2021 |